Currency Economy

China likely to approve BioNTech’s COVID-19 vaccine by July: WSJ

Coronavirus (Apr 16, 2021 08:45AM ET)China likely to approve BioNTech's COVID-19 vaccine by July: WSJ© Reuters. FILE PHOTO: Syringes are seen in front of a displayed Biontech logo in this illustration

(Reuters) – China is planning to authorize the COVID-19 vaccine developed by Germany’s BioNTech SE (NASDAQ:BNTX) by July, the Wall Street Journal reported on Friday, citing people familiar with the matter.

If approved, it would become the first foreign COVID-19 vaccine to be authorized in the country.

Chinese officials are reviewing clinical-trial data for the vaccine and are expected to authorize it for domestic use within the next 10 weeks, the report said.

BioNTech did not immediately respond to a Reuters request for comment.

The German drugmaker announced a potential deal with Shanghai Fosun Pharmaceutical Group Co Ltd in August to supply 10 million doses of their COVID-19 vaccine to Hong Kong and Macau. (

The vaccine, developed in collaboration with Pfizer Inc (NYSE:PFE), is already approved in several countries, including the United States, the United Kingdom and Israel.China likely to approve BioNTech’s COVID-19 vaccine by July: WSJAdd a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s